The valorization of sewage sludge and food waste to produce energy and fertilizers is a well-stablished strategy within the circular economy. Despite the success of numerous laboratory-scale experiments in converting waste into high-value products such as volatile fatty acids (VFAs), large-scale implementation remains limited due to various technical and environmental challenges. Here, we evaluate the environmental performance of a hypothetical large-scale VFAs biorefinery located in Galicia, Spain, which integrates fermentation and purification processes to obtain commercial-grade VFAs based on primary data from pilot plant operations.
View Article and Find Full Text PDFEnvironmental certification has come up as a voluntary action to demonstrate a minimum quality level when it comes to the introduction of ecological-friendly principles in decision-making. However, most of the work done so far has focused on the food and agroforestry sectors and on the production and processing stages of the value chain rather than end-of life strategies. The present study aims to provide a roadmap that facilitates the evaluation of the performance wastewater facilities from sustainable and circularity perspectives.
View Article and Find Full Text PDFPurpose: This study is to evaluate duration of oocyte cryostorage and association with thaw survival, fertilization, blastulation, ploidy rates, and pregnancy outcomes in patients seeking fertility preservation.
Methods: Retrospective cohort study to evaluate clinical outcomes in patients who underwent fertility preservation from 2011 to 2023 via oocyte vitrification for non-oncologic indications. Primary outcome was thaw survival rate.
Purpose Of Review: In this review, we discuss which patients with metastatic clear cell renal cell carcinoma (mRCC) may be most suitable for frontline tyrosine kinase inhibitor (TKI) monotherapy, a treatment option supported by emerging long-term efficacy data including overall survival and quality of life. We specifically focus on tivozanib, a potent and selective inhibitor of vascular endothelial growth factor receptor, which has comparable efficacy to other single-agent TKIs in frontline treatment for mRCC while exhibiting fewer off-target side effects.
Recent Findings: Combination therapy with TKIs and checkpoint inhibitors (CPIs) and CPI/CPI combination therapies, as well as TKI monotherapy are recommended frontline treatment options for mRCC.
Purpose: To survey United States (U.S.) pediatric hospital websites for information about fertility preservation (FP) for transgender patients.
View Article and Find Full Text PDF